- Exact Sciences (NASDAQ:EXAS +5.5%) offers 10M shares of common stock at $12.75/share to the public. ~$119.7M net proceeds will fund regulatory approval and commercial activities for Cologuard, other product development efforts and general corporate uses.
- Underwriters over-allotment is 1.5M shares.
- Closing date is April 9.
- 221 mutual funds have positions, up from 219 last year.
Exact prices its secondary offering
Recommended For You
More Trending News
About EXAS Stock
Related Stocks
Symbol | Last Price | % Chg |
---|---|---|
EXAS | - | - |
Exact Sciences Corporation |